1. Introduction
Bone formation includes two important processes, namely intramembranous ossification that results in flat bones (bones of the face, most bones of cranium and clavicles) and endochondral ossification that forms long bones (tibia, femur, humerus, and radius) [
1]. While the intramembranous process is characterized by initial differentiation of mesenchymal cells into osteoblasts that release osteoid (matrix composed of collagen and proteins) and then become osteocytes followed by blood vessel formation, endochondral pathway starts with the replacement of hyaline cartilage composed of chondroblasts differentiated from mesenchymal cells by perichondrium derived osteoblasts that secret bone matrix; in turn, this matrix prevents from the diffusion of the blood providing nutrients to the cartilage tissue leading to chondroblast apoptosis and cartilage tissue destruction, which cause the penetration of surrounding blood vessel into free spaces to create medullary cavity [
2]. In both processes, contribution and the close link between mesenchymal cells and blood vessels are crucial. In a hip replacement procedure where damaged femoral head and acetabulum are replaced by a metal hip inserted to the femur, bone grafts are sometimes required to improve osteointegration between the implant and the host’s bone. These bone grafts when pressed into the space between the implant and the femur, they may also attract adjacent osteoblasts, mesenchymal stem cells to migrate and reside in the graft. Furthermore, the existing blood vessels present in bone marrow carry oxygen and nutrients to the cells and possibly promote angiogenesis in the bone graft. Despite high vasculature, bone marrow has been considered as a hypoxic tissue [
3,
4], thus the study of osteogenesis and angiogenesis in the absence of oxygen could be useful to investigate the physiological state and may be utilized to create an in vitro pre-vascularized engineered bone graft for future implantation.
In the literature, HUVEC was found to inhibit BMSC differentiation into osteoblast in indirect coculture (at 1:1 ratio) [
5]. On the contrary, in the 1:1 direct coculture of HUVEC and the cells with MSC characteristics, such as dental pulp stem cells and dental follicle derived stem cells, both osteogenic and angiogenic potentials are increased [
6,
7] respectively. According to Yamamoto et al., 2019 [
8] and Zhang et al. 2017 [
9], direct coculture at the above ratio of HUVEC and BMSC also promotes angiogenic markers. We, therefore hypothesize that direct coculture of HUVEC and BMSC (1:1 ratio) may promote the generation of a pre-vascularized bone graft.
Hypoxia-inducible factor 1 (HIF-1) activates the expression of genes related to angiogenesis (VEGF), erythropoiesis (EPO), and metabolism (ALDA, ENO1, LDHA, PFKL, PGK1) [
10]. However, Gawlitta et al. 2012 [
11] demonstrated that coculture of BMSC with the endothelial colony-forming unit as pellets in the osteogenic medium in hypoxic conditions impedes vasculogenesis of engineered bone. It is consistent with the findings of Griffith et al., 2009 [
12] where 1% oxygen hypoxia was proven to decrease in vitro angiogenesis of the engineered tissue composed of HUVEC and normal human lung fibroblasts—a type of stromal cells. It should be noted that a hypoxic incubator cannot guarantee complete hypoxia as once the incubator’s door is open, the cells inside could be in contact with oxygen and it also requires time for the incubator to lower the oxygen back to the required level. Although the hypoxic chamber overcomes this drawback as the working bench and trays for placing cell plates are inside the hypoxic chamber, it can be limited solely for the pilot experiment. To address these problems, we used two reagents previously known for simulating hypoxia namely Cobalt(II) chloride (CoCl
2) and Dimethyloxaloylglycine (DMOG) for coculture system to compare with in normoxia.
In this study, we aimed to evaluate cell proliferation of BMSC and HUVEC in direct coculture in normoxia and hypoxia-induced by hypoxic agents. To better simulate the inflammatory condition, IL-1β was also added to the culture medium in normoxia. Furthermore, in vitro osteogenesis and angiogenesis were analyzed to determine the role of oxygen in these two processes. To our knowledge, this is the first study addressing the differentiation of BMSC and HUVEC in direct coculture system under the effect of hypoxia stimulated by chemical reagents. The findings of this study could be applied in the production of engineered bone grafts with osteoinductivity and pro-angiogenic characteristics for implantation.
2. Materials and Methods
2.1. Cell Isolation and Culture
2.1.1. Isolation and Expansion of BMSC
Approval of the procedure was obtained from the Ethical Committee of IRCCS Istituto Ortopedico Galeazzi (Protocol v02 del 09/06/2017). Four patients undergoing hip replacement procedures were selected for the study with their informed consent. The patients aged between 50 and 80 years old with a body mass index (BMI) from 18 to 30 kg/m2. None of them had a history of disease related to infection with HIV or HBV/HCV, bone metabolism, and joint inflammation.
Bone marrow aspirate from the femoral canal was collected and washed twice with 1× Phosphate buffer saline (PBS) at 1,700×
g for 10 min at room temperature (RT). Nucleated cells were counted and plated at density 5 × 10
4 cells/cm
2 in medium containing alpha minimum essential medium (αMEM, Thermofisher, Bleiswijk, Netherlands), 10% volume/volume (
v/v) fetal bovine serum (FBS, Euroclone, Milan, Italy), and 1% (
v/v) penicillin/streptomycin/glutamine (P/G/S, Thermofisher, Bleiswijk, Netherlands) supplemented with 1 ng/mL recombinant human FGF-2 (R&D Systems, Minneapolis, MN, USA). The primary cells were incubated in the 37 °C and 5% CO
2 incubator for 1 week then the medium was changed twice per week. The cells were expanded up to Passage 4 (P4). We previously demonstrated that BMSC isolated following this protocol have typical characteristics of MSC such as they are devoid of hematopoietic stem cells markers (CD34, CD45) but express markers of MSC including CD73, CD90, and CD106; they are also able to differentiate into osteoblasts, adipocytes, and chondrocytes [
13].
2.1.2. HUVEC Culture
Three different cri-vials containing HUVEC were purchased from PromoCell (Heidelberg, Germany). The provider guaranteed that the cells were tested for cell marker expression of VWF, CD31, and Dil-Ac-LDL uptake assays and they were absent from HIV, HBV, HCV, and microbial contamination. The cryopreserved cells (500,000 cells/cri-vial) immediately upon arrival were plated on 1–10 cm dish in complete EGM2 medium composed of Endothelial cell growth medium 2 (C-22011, PromoCell, Heidelberg, Germany) supplemented with SupplementMix (C-39211, PromoCell, Heidelberg, Germany). Alternatively, the complete EGM2 contains 2% (v/v) FBS, 5 ng/mL Epidermal Growth Factor (EGF), 10 ng/mL FGF-2, 20 ng/mL Insulin-like Growth Factor (IGF), 0.5 ng/mL VEGF 165, 1 μg/mL ascorbic acid, 22.5 μg/mL heparin, and 0.2 μg/mL hydrocortisone. Then the cells were expanded in a ratio 1:4 up to P4.
2.1.3. Coculture of BMSC and HUVEC
The direct coculture method at ratio 1:1 was used to cultivate BMSC and HUVEC together. Complete EGM2 medium was utilized to initially coculture both types of cells as EGM2 could increase the plasticity of BMSC [
14]. To mimic the inflammatory response, 100 pg/mL IL-1β (R&D Systems, Minneapolis, MN, USA) was added to the cell culture, its concentration used in this study was inferred from literature data [
15]. For in vitro hypoxic conditions, either COCl
2 or DMOG were added to the Complete medium at concentration 100 μM [
16] and 0.5 mM [
17], respectively. Both COCl
2 and DMOG were purchased from Sigma (Schnelldorf, Germany). For the differentiation assay, besides COCl
2 and DMOG, the cells in coculture were also incubated in the hypoxic chamber where oxygen level was maintained at 1% to compare better different hypoxic stimuli.
2.2. Cell Proliferation Assay
Cells for monoculture (BMSC only, HUVEC only) and coculture (BMSC + HUVEC) were plated at density 2,000 cells/well on 96 well plates in quintuplicate in different media which are medium Complete and medium Complete supplemented with either 100 pg/mL IL-1β (IL-1β) or 100 μM COCl2 (COCl2) or 0.5 mM DMOG (DMOG). The media were freshly changed two times per week. At each time point starting from day 1 to day 6, the cells were washed once with 1× PBS, stained with 0.75% g/mL crystal violet solution for 20 min at RT, and finally washed 5 times with distilled water, the powder was supplied by Sigma (Schnelldorf, Germany). Photos of dried cells were taken by using a bright-field microscope (Leica, Wetzlar, Germany), then 100 μL of eluent solution (50% (v/v), absolute ethanol, and 1% (v/v) acetic acid) was added to each well to dissolve the dye absorbed by the cells, and absorbance was measured at 550 nm by using a microplate reader (Multiskan Ascent, Thermo Labsystems, Midland, Canada).
2.3. In Vitro Osteogenic Differentiation
BMSC and HUVEC were cocultured in medium Complete EGM2 at following densities: 50,000 cells/well of 24 well plate (for alizarin Red S staining and immunohistochemistry (IHC)); 300,000 cells/well of 6 well plate for quantitative polymerase chain reaction (qPCR); 700,000 cells/10 cm dish for Enzyme-linked immunosorbent assay (ELISA). When the cells reached total confluence, they were switched to i) osteogenic medium (OM) which is EGM2 containing 2% FBS, 50 μg/mL ascorbic acid (Sigma, Schnelldorf, Germany)), 10mM β glycerolphosphate (Merck, Schnelldorf, Germany)) and 10−7 M dexamethasone (Sigma, Schnelldorf, Germany)); ii) OM added 100 100 pg/mL IL-1β; iii) OM supplemented with 100 μM COCl2, iv) OM added 0.5 mM DMOG and v) OM in 1% O2. The addition of IL-1β was to evaluate osteogenesis in inflammatory conditions while the supplement of COCl2 and DMOG was to examine osteogenic differentiation in hypoxic conditions. Moreover, EGM2 supplemented with 2% FBS only was used as a control (CTR) medium. The media were freshly changed twice per week. The experiment lasted for 9 days.
2.4. Alizarin Red S Staining
Alizarin Red S staining was used to observe calcium deposits formed by differentiated cells (osteoblasts) in osteogenic conditions. Cells were washed once with PBS, fixed in 10% formalin for 10 min at RT, washed twice with PBS, subsequently stained in 2% (w/v) Alizarin Red S solution pH 4.2 (the powder was supplied by Sigma, Schnelldorf, Germany) for 10 min at RT, and finally washed with distilled water. Photos of the plates containing dry stained cells were taken by using the scanner Epson V200 (Epson, Suwa, Japan).
2.5. IHC
The confluent cocultured cells were induced for osteogenesis in four different media as mentioned above. At the end of each time point (day 2 and day 9), cells were washed once with PBS, fixed in 10% formalin for 10 min at RT, then washed again with PBS. 0.2% Triton (Sigma, Schnelldorf, Germany) in PBS was added to the cells for 10 min to permeabilize the membrane. Subsequently, cells were incubated with 4% H2O2 for 30 min to block the endogenous peroxidase, then in 1 mg/mL hyaluronidase type II (Sigma, Schnelldorf, Germany) in PBS pH 6 for 15 min at 37 °C to loosen the matrix. Then, nonspecific blocking was performed by incubating the cells in pure FBS for 30 min at RT. Immediately after this blocking step, cells were incubated with 1st antibodies against VEGF (1:1000, ab46154, Abcam, Cambridge, UK), VWF (1:500, #65707, Cell Signaling, Beverly, MA, USA), and Collagen type I (1:1500, ab138492, Abcam, Cambridge, UK) for 2 h, RT. The cells were then washed with PBS for 3 × 5 min and incubated with biotinylated anti-rabbit secondary antibody (1:500, Dako Agilent, Santa Clara, CA, USA) for 30 min at RT. The 1st and 2nd antibodies were diluted in 10% FBS in PBS. Negative control (IgG control) sample was also performed by leaving the section in 10% FBS without 1st antibody. After being washed with PBS for 3 × 5 min, the cells were incubated with streptavidin horseradish peroxidase (HRP) conjugate (Dako Agilent, Santa Clara, CA, USA) for 30 min at RT. Subsequently, the cells were washed with PBS for 3 × 5 min. For VEGF and VWF recognition, cells were stained with 3,3′Diaminobenzidine (DAB, Dako Agilent, Santa Clara, CA, USA) for 3 min and counterstained in Mayer’s hematoxylin (Sigma, Schnelldorf, Germany) for 2 min. For Collagen type I detection, the cells were stained with DAB-Nikel (Vector Laboratories, Burlingame, California, CA, USA) without the counterstaining step. Finally, the sections were mounted with DPX mounting medium.
2.6. ELISA
ELISA was used to quantify VEGF and VWF released to the media. The confluent cocultured cells were washed twice with sterile PBS, then the dishes were divided into three groups:
- i)
Complete EGM2, Complete EGM2 + COCl2, Complete EGM2 + DMOG, Complete EGM2 in 1% O2
- ii)
CTR, CTR + COCl2, CTR + DMOG, CTR in 1% O2
- iii)
OM, OM + COCl2, OM + DMOG, OM in 1% O2
The cells were incubated in the above media for 24 h, then were washed twice with sterile PBS and maintained in the medium EGM2 containing 0.1% FBS only (2 mL/10 cm dish) for another 24 h. Consequently, the supernatant was collected, centrifuged for 10 min at 12,000 × g at 4 °C to remove cell debris and stored at –20 °C. Quantification of VEGF and VWF were measured by using Human VEGF Quantikine ELISA kit (DVE00, R&D Systems, Minneapolis, MN, USA) and Human VWF kit (RAB0556, Sigma, Schnelldorf, Germany), respectively. Absorbance was read at wavelength as recommended instruction of the kits by using a microplate reader (Multiskan Ascent, Thermo Labsystems, Midland, Canada). Each sample was performed in duplicate. The experiments were repeated three times on three different samples.
2.7. qPCR
qPCR was performed to analyze the gene expression. Total RNA was isolated by using RNeasy Mini Kit (Qiagen, Hilden, Germany). The quality and quantity of RNA were measured by NanoDrop 8000 (Thermo Fisher Scientific, Wilmington, DE, USA). 1 μg of RNA was reversely transcribed following the instruction of ImProm II reverse Transcription System (Promega, Madison, WI, USA). cDNA was amplified by using the PowerUp SYBR master mix (Thermofisher, Bleiswijk, Netherlands) on the 7500 Fast Realtime PCR System (Applied Biosystems, Waltham, MA, USA). The sequences of primers are listed in
Table 1. The reaction plates were initially held at 50 °C for 20 s and then 95 °C for 10 min, subsequently, the cycling stage was performed at 95 °C for 15 s and then 60 °C for 1 min, this cycling stage was repeated for 40 cycles, and finally, the reactions were set at for 95 °C for 15 s, followed by 60 °C for 1 min, 95 °C for 30 s, and 60 °C for 15 s for the melting curve. Gene expression was determined according to the 2(-delta delta C(T)) method [
18].
>2.8. Statistic Analysis
All data are presented as means and standard error of the mean (SEM) of three independent experiments (n = 3). Comparisons were performed by one-way ANOVA followed by post-hoc Tukey’s multiple comparisons test (for ELISA analysis) or two-way ANOVA (all other data). Statistical analysis was performed using GraphPad Prism Version 6.0a software with statistical significance set at p < 0.05.
4. Discussion
Bone fracture healing of long bones is a complex and dynamic process orchestrated by three main phases namely inflammation, reparation and remodeling [
20,
21]. In inflammatory phase, blood vessels carry cells of the immune system including platelets, neutrophils, and macrophages to the wound site, in turn, these cells are activated to release inflammatory cytokines to attract other cells. In the reparative step, the periosteal cells migrate and differentiate into chondrocytes at the wound to make callus followed by the matrix calcification, angiogenesis and substitution of chondrocytes by osteoblast. Finally, remodeling occurs to form compact bone and maturation of osteoblasts to osteoclast. Thus, the blood vessel is considered as the key element to initialize fracture healing and plays a critical role in cell migration, proliferation, and early differentiation.
In total hip arthroplasty, a metal prosthesis connects the proximal femur with the acetabulum to replace the physiological hip function. However, over time a revision surgery may be required mainly due to prostheses instability and mechanical loosening [
22]. In the revision procedure, synthetic bone grafts could be used to increase bone stock to favor integration of the host body and prostheses [
23]. Recently, bone tissue engineering has received much interest as it uses synthetic bone and cells to induce osteogenesis and osteoinduction [
24].
To increase the number of mammalian cells in vitro, scientists often incubate them in normoxia, which provides atmospheric oxygen level (20%–21%), however physiological oxygen in tissues falls in 2%–9% that can be considered as hypoxia, particularly acute hypoxia (1% O
2) can exist at some tissues such as kidney, bone marrow, thymus [
4]. It should be noted that the environment in the bone fracture site is hypoxic because of blood extravasation leading to interruption of oxygen supply and strong consummation of oxygen of cells recruited to the wound [
25], thus the role of oxygen in bone healing should be considered. In this study, we used CoCl
2 and DMOG to stimulate hypoxia. CoCl
2 inhibits von Hippel–Lindau protein (
pVHL) binding to oxygen degrading domain consisting of proline residues of HIF-1α thus preventing HIF-1α hydroxylation by oxygen-dependent prolyl hydroxylases (PHD) [
1,
26] whereas DMOG directly inhibits PHD leading to HIF-1α stability [
27,
28].
We investigated the effect of hypoxia on cell proliferation, osteogenesis and angiogenesis in vitro of direct coculture system of BMSC—the progenitor cells able to differentiate into osteoblast and chondrocyte—and HUVEC—endothelial cells widely used for the study of blood vessel formation. Our findings are summarized as follows:
1. We observed that the presence of atmospheric oxygen can promote viability and proliferation of cells in both monoculture and coculture, thus for expansion of BMSC and HUVEC together in normoxia is superior to in hypoxia. Endothelial cells in the endothelium are the first cells in contact with blood, thus changes in oxygen concentration of the blood could affect the cell types. Our evaluation of the impact of oxygen level on human BMSC proliferation is consistent with findings of Holzwarth et al., 2010 [
17] but in contrast with Grayson et al., 2007 [
29]. In this study, we used the complete medium containing growth factor FGF-2 for BMSC culture, Holzwarth et al., 2010 [
17] used 5% (
v/v) human plasma that also consists of a cocktail of growth factors and cytokines whereas Grayson et al., 2007 [
29] did not use any supplement of growth factors except for standard FBS. We hypothesize that the effect of oxygen on human BMSC proliferation is dependent on components in the cell culture medium. BMSC slowly grows in culture, the addition of factors required for proliferation provided that they maintain cell stemness should be recommended.
2. Normoxia benefits in vitro bone formation of BMSC and HUVEC in coculture while hypoxia promotes angiogenesis. BMSC and HUVEC were cocultured up to full confluence then induced to osteogenic differentiation. Calcium deposits produced by osteoblast during mineralization are an indication of successful in vitro osteogenesis. In normoxia, after 9 days, the cells formed nice calcium deposits showed by red color after staining with Alizarin Red S whereas the cells in hypoxia did not. Expression of genes specific for bone formation (ALP) was also higher in normoxia than in hypoxia. Moreover, in both normoxia and hypoxia, we observed the appearance of collagen type I—marker of extracellular matrix of bone, but the matrix of the cells in normoxia was much denser particularly after 9 days in culture showing strong crosslinking of proteins and matrix maturation. Considering that collagen type I is the most abundant protein accounting for more than 90% of bone mass and provides tensile strength as well as load-bearing for bone connective tissue [
30] thus it is indispensable to evaluate its expression in the study of bone formation.
Simultaneously with osteogenesis examination, we also investigated VWF expression of cells in osteogenic medium. All of the cells expressed this endothelial marker, however over time the cells stimulated in hypoxia indicated stronger signal. In particular, DMOG could be more efficient compared to CoCl2 as the cells incubated in DMOG produced more intense brown color presenting for VWF than CoCl2, this also correlates with the qPCR result. In addition, we discovered that short incubation (24 h) in hypoxia does not change the concentration of VWF released by the cells compared to normoxia.
VEGF is the fundamental element of angiogenesis—new blood vessel formation from existing vasculature [
31,
32]. All of the cells incubated in both normoxia and hypoxia strongly expressed VEGF especially the cells stimulated by CoCl
2 and DMOG after 2 days of treatment. More surprisingly, we discovered that after a short treatment (24 h) concentration of VEGF released into the culture supernatant produced by cells incubated in hypoxia surged particularly in the cells stimulated by DMOG, while the level of VWF released by cells remained unchanged between normoxia and hypoxia. Importantly, by profiling VWF and VEGF expression of the cells under the effect of two chemicals simulating hypoxia, we found that DMOG could be a better candidate compared to CoCl
2. Considering that long hypoxia (more than 3 days) could hinder cell proliferation and viability, short hypoxia (1 day) is sufficient to push VEGF production while not affecting VWF expression and normoxia is critical for osteogenesis, thus to obtain both bone and blood formation, normoxia should be applied initially for cell culture to induce osteogenesis followed by short treatment in hypoxia to facilitate angiogenesis.
3. Local inflammation is the first phase in wound healing, thus the presence of pro-inflammatory cytokines could be beneficial to trigger successive phases in the healing process. Thus, we used IL-1β to mimic the inflammatory environment. We found that the addition of IL-1 β to the medium at 100 pg/mL concentration increased cell proliferation, did not interfere with osteogenic differentiation and did not alter angiogenesis of BMSC and HUVEC cocultured in normoxia. However, the level of cytokines must be limited otherwise systematic inflammation could occur and cause destruction of tissue matrix because of the production of matrix metalloproteinases (MMPs) [
33,
34]. This observation may imply that implantation of scaffolds seeded with BMSC and HUVEC in the inflamed joint could be possible, however further studies on other cytokines and longer time duration (more than 9 days) should be done.
BMSC represents a possible application for patients suffering from musculoskeletal injuries. Our preliminary study showed that direct coculture of BMSC and endothelial cells at ratio 1:1 could maintain both osteogenesis and angiogenic potentials depending on oxygen concentration in culture, which could be modified by the addition of hypoxia-induced reagents. Further studies both in vitro and in vivo are needed to better understand the complex relationship between osteogenesis and angiogenesis to generate newly engineered scaffolds able to promote bone regeneration.